NCT03495011View on ClinicalTrials.gov

MRI Characterization of Mammographically Detected DCIS

Active, not recruitingOBSERVATIONAL
Enrollment

122

Participants

Timeline

Start Date

April 20, 2018

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2032

Conditions
Breast Cancer, Stage 0
Interventions
DIAGNOSTIC_TEST

Breast MRI

Quantitative, multiparametric breast MRI

OTHER

Laboratory Biomarker Analysis

Only patients with pure DCIS on surgical excision will have advanced pathologic markers and Oncotype Dx DCIS Score testing.

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Washington

OTHER

NCT03495011 - MRI Characterization of Mammographically Detected DCIS | Biotech Hunter | Biotech Hunter